| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Analysis of cytotoxicities of platinum compounds
|
Goodisman, Jerry
|
|
2005
|
57 |
2 |
p. 257-267
|
artikel
|
| 2 |
Antiproliferative activity of contragestazol (DL111-IT) in murine and human tumor models in vitro and in vivo
|
Yang, Bo
|
|
2005
|
57 |
2 |
p. 268-273
|
artikel
|
| 3 |
Camptothecin analogs with enhanced activity against human breast cancer cells. I. Correlation of potency with lipophilicity and persistence in the cleavage complex
|
Adams, David J.
|
|
2005
|
57 |
2 |
p. 135-144
|
artikel
|
| 4 |
Camptothecin analogs with enhanced activity against human breast cancer cells. II. Impact of the tumor pH gradient
|
Adams, David J.
|
|
2005
|
57 |
2 |
p. 145-154
|
artikel
|
| 5 |
Combination of topotecan and cisplatin in relapsed patients with small cell lung cancer: a phase II study of the hellenic cooperative oncology group (HeCOG)
|
Christodoulou, Christos
|
|
2005
|
57 |
2 |
p. 207-212
|
artikel
|
| 6 |
Dihydroartemisinin downregulates vascular endothelial growth factor expression and induces apoptosis in chronic myeloid leukemia K562 cells
|
Lee, Jun
|
|
2005
|
57 |
2 |
p. 213-220
|
artikel
|
| 7 |
Experimental study of the inhibition of human hepatocarcinoma Bel7402 cells by the tripeptide tyroserleutide(YSL)
|
Lu, Rong
|
|
2005
|
57 |
2 |
p. 248-256
|
artikel
|
| 8 |
Expression of VDR and CYP24A1 mRNA in human tumors
|
Anderson, Mark G.
|
|
2005
|
57 |
2 |
p. 234-240
|
artikel
|
| 9 |
Gemcitabine plus celecoxib (GECO) in advanced pancreatic cancer: a phase II trial
|
Ferrari, Vittorio
|
|
2005
|
57 |
2 |
p. 185-190
|
artikel
|
| 10 |
Intravenous busulfan in adults prior to haematopoietic stem cell transplantation: a population pharmacokinetic study
|
Nguyen, L.
|
|
2005
|
57 |
2 |
p. 191-198
|
artikel
|
| 11 |
Low folate conditions may enhance the interaction of trifluorothymidine with antifolates in colon cancer cells
|
Temmink, Olaf H.
|
|
2005
|
57 |
2 |
p. 171-179
|
artikel
|
| 12 |
4-methylumbelliferone, a hyaluronan synthase suppressor, enhances the anticancer activity of gemcitabine in human pancreatic cancer cells
|
Nakazawa, Hideaki
|
|
2005
|
57 |
2 |
p. 165-170
|
artikel
|
| 13 |
Pharmacodynamic effects of high dose lovastatin in subjects with advanced malignancies
|
Holstein, Sarah A.
|
|
2005
|
57 |
2 |
p. 155-164
|
artikel
|
| 14 |
Pharmacokinetics, pharmacodynamics and adherence to oral topotecan in myelodysplastic syndromes: a Cancer and Leukemia Group B study
|
Klein, Cheri E.
|
|
2005
|
57 |
2 |
p. 199-206
|
artikel
|
| 15 |
Prospective evaluation of carboplatin AUC dosing in patients with a BMI ≥27 or Cachexia
|
Herrington, Jon D.
|
|
2005
|
57 |
2 |
p. 241-247
|
artikel
|
| 16 |
Structure-activity study of the interaction of bioreductive benzoquinone alkylating agents with DNA topoisomerase II
|
Hasinoff, Brian B.
|
|
2005
|
57 |
2 |
p. 221-233
|
artikel
|
| 17 |
Thiolo-, thiono- and dithiocarbonate and thiocarbamate derivatives of demethylpenclomedine as novel anticancer agents
|
Struck, Robert F.
|
|
2005
|
57 |
2 |
p. 180-184
|
artikel
|
Tijdschrift beschrijving